Related Experiment Videos
Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids
S Toma1, L Isnardi, L Riccardi
1National Institute for Cancer Research (IST), Department of Medical Oncology, University of Genoa, Italy.
Abstract:
Induction of apoptosis in MCF-7 breast carcinoma cell line by various retinoids was measured by cytofluorimetry and DNA fragmentation assay. Retinoids with marked or high selectivity for RAR alpha, RAR beta, RAR gamma or RXR alpha were tested. All these retinoids were capable of inducing apoptosis, in a dose- and time-dependent way. MCF-7 cell line expressed RAR alpha, RAR gamma and RXRs, but not RAR beta. Compared to untreated MCF-7 cells, after 2 days of incubation with each of the selective retinoids, a substantial increase in apoptotic cells was observed, even at the lowest concentration of 10(-8) M. Among the various analysed selective retinoids only slight differences were observed. All-trans retinoic acid and 13-cis retinoic acid induced apoptosis only after 6 days and 9-cis-retinoic acid after 4 days of incubation. Since all receptor selective retinoids substantially inducedapoptosis, it may be concluded that RAR alpha, RAR gamma and RXR alpha are able to mediate programmed cell death in the tested tumor cell line. Highly selective retinoid receptor agonists and antagonists may be useful for clarifying the function of retinoid receptors and for further progress in the field of cancer prevention and therapy by retinoids.
Insights
Selective retinoids effectively induce apoptosis in MCF-7 breast cancer cells by activating specific retinoid receptors. This finding highlights the potential of retinoid receptor modulators in cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Retinoids are crucial for cell differentiation and proliferation.
- Aberrant retinoid signaling is implicated in various cancers, including breast carcinoma.
- Understanding retinoid receptor function is key to developing novel cancer therapies.
Purpose of the Study:
- To investigate the apoptosis-inducing effects of selective retinoids on the MCF-7 breast carcinoma cell line.
- To identify which retinoid receptors mediate these effects in MCF-7 cells.
- To explore the therapeutic potential of retinoid receptor agonists and antagonists.
Main Methods:
- Utilized cytofluorimetry and DNA fragmentation assays to measure apoptosis.
- Tested retinoids selective for Retinoic Acid Receptors (RAR) alpha, beta, gamma, and Retinoid X Receptors (RXR) alpha.
- Incubated MCF-7 cells with varying concentrations and durations of retinoid exposure.
Main Results:
- All tested selective retinoids induced apoptosis in a dose- and time-dependent manner.
- MCF-7 cells express RAR alpha, RAR gamma, and RXRs, but not RAR beta.
- Significant apoptosis was observed at low retinoid concentrations (10(-8) M) within 2 days, suggesting RAR alpha, RAR gamma, and RXR alpha mediate programmed cell death.
Conclusions:
- RAR alpha, RAR gamma, and RXR alpha mediate retinoid-induced apoptosis in MCF-7 breast cancer cells.
- Selective retinoid receptor agonists and antagonists show promise for cancer prevention and therapy.
- Further research into retinoid receptor functions can advance retinoid-based cancer treatments.